• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Cardiac Science Delivers Advanced Web-Enabled Cardiology Data Management System

Posted on: Wednesday, 21 September 2005, 09:00 CDT

BOTHELL, Wash., Sept. 21 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiology products, announced today that it is shipping a web version of its popular Pyramis(R) cardiology data management system used by hospitals. This sophisticated system allows storage, editing, retrieval, and sharing of data from electrocardiographs, cardiac stress tests, Holter tests, and 12-lead ECGs from bedside monitors. With the new version installed, authorized users are easily able to access the data, with full privileges, from anywhere.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )

According to Kathryn Coleman, CCT, the Lead Tech for Noninvasive Cardiovascular Diagnostic Services at St. Agnes Hospital in Fresno, CA, "Pyramis has made it easier for our Medical Staff to read ECGs online, which in turn has improved our efficiency and productivity. We had a high level of physician satisfaction with the original system, but we're finding that they're even more pleased with the Web version."

In healthcare today, there is a strong drive towards digitization of patient data for ease of access and efficiency. This is facilitated by direct import of information from medical devices into data management systems and by integrating various data management systems together to provide a single point of access. Pyramis(R) is a world class data management system from Cardiac Science that pulls data together from various diagnostic cardiology devices. The release of the web version of Pyramis(R) will facilitate integration with other data management systems and make digitization easier for customers.

"Over the past two years, we have made several improvements to Pyramis(R), including this new web version. We are very excited about the possibilities this will open up for our customers and, as a result, the potential for worldwide growth for our data management and device solutions. The new web version also supports our agreement with the Cerner Corporation by providing the communication infrastructure to seamlessly integrate our respective management systems," stated Atul Jhalani, vice president of marketing.

In November, 2004 Cardiac Science (at the time Quinton Cardiology) announced a global value-added reseller agreement with the Cerner Corporation under which Cerner distributes the Pyramis(R) data management system. As part of this agreement, Cerner will develop an interface to Pyramis(R) with its hospital information system architecture, Cerner Millennium(R), expanding the ability of both companies to provide advanced, integrated solutions for managing cardiology data for hospitals and physicians offices.

About Cardiac Science Corporation

Cardiac Science Corporation develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.

The company is the successor to various entities that have owned and operated cardiology related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science Corporation is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.

Contact Mike Matysik Senior vice president and chief financial officer (425) 402-2009 Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, those relating to Cardiac Science Corporation's future revenue growth and profitability that involve a number of risks and uncertainties. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe,""expect,""intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the registration statement on Form S-4/A that was filed by Cardiac Science Corporation under the name CSQ Holding Company on July 28, 2005, under the caption "Risk Factors," and in the Annual Reports of Quinton Cardiology Systems, Inc. and Cardiac Science, Inc. on Form 10-K for the year ended December 31, 2004, under the captions "Certain Factors that May Affect Future Results" and in other documents, we file with the Securities and Exchange Commission. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk photodesk@prnewswire.com

Cardiac Science Corporation

CONTACT: Mike Matysik, Senior vice president and chief financial officerof Cardiac Science Corporation, +1-425-402-2009

Web site: http://www.cardiacscience.com/

Source: PRNewswire-FirstCall

More News in this Category